How Increasing Medical Access to Opioids Contributes to the Opioid Epidemic

Evidence from Medicare Part D

Published in: Journal of Health Economics, Volume 71 (May 2020). doi: 10.1016/j.jhealeco.2019.102286

Posted on RAND.org on June 26, 2020

by David Powell, Rosalie Liccardo Pacula, Erin Audrey Taylor

Read More

Access further information on this document at Journal of Health Economics

This article was published outside of RAND. The full text of the article can be found at the link above.

Drug overdoses involving opioid analgesics have increased dramatically since 1999, representing one of the United States' top public health crises. Opioids have legitimate medical functions, but they are often diverted, suggesting a tradeoff between improving medical access and nonmedical abuse. We provide causal estimates of the relationship between the medical opioid supply and drug overdoses using Medicare Part D as a differential shock to the geographic distribution of opioids. Our estimates imply that a 10% increase in opioid medical supply leads to a 7.1% increase in opioid-related deaths among the Medicare-ineligible population, suggesting substantial diversion from medical markets.

Research conducted by

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.